- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04853173
Modality of Pain Management in Ambulatory Tonsillectomy Surgery in Adults (DACAA)
July 19, 2022 updated by: Centre Hospitalier Universitaire de Besancon
Modality of Pain Management in Ambulatory Tonsillectomy Surgery in Adults: External Pilot Study
No SFORL recommendation for adult ambulatory tonsillectomy.
This study would allow the establishment of an ambulatory management during an adult tonsillectomy.
This would allow a return home from J0 for the patient and therefore would improve the comfort of the patients and reduce the cost associated with a conventional hospitalization over several days.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Laurent TAVERNIER, PU-PH
- Phone Number: 0381669360
- Email: ltavernier@chu-besancon.fr
Study Locations
-
-
-
Besançon, France, 25000
- Recruiting
- CHU Besançon
-
Contact:
- Laurent TAVERNIER
- Phone Number: 0381669360
- Email: ltavernier@chu-besancon.fr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- programmed Tonsillectomy surgery
Exclusion Criteria:
- Congenital or acquired hemostasis disorder
- Indication of uvulo-bike-pharyngo-plasty
- Contraindication to the use of one of the protocol molecules including pregnancy
- Allergy to analgesic treatments used in the study
- Ongoing analgesic treatment that cannot be interrupted
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: ambulatory protocol after adult tonsillectomy
prescription of analgesics for outpatient procedure with hospital surveillance
|
use a post-operative analgesia protocol suitable for outpatient surgery.
Namely a protocol of analgesia based on the taking of drugs per bone (by mouth) and not intravenous.
Pain evaluation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Assess pain management modalities in ambulatory tonsillectomy surgery in adults through post-operative pain assessment, with a defined analgesia and anesthesia protocol adapted to ambulatory management.
Time Frame: 14 days
|
Pain measured by self-assessment by Analog Visual Scale (0-10).
If score is under 4 = efficacity of ansthesia protocol
|
14 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 28, 2021
Primary Completion (Anticipated)
November 28, 2022
Study Completion (Anticipated)
November 28, 2022
Study Registration Dates
First Submitted
April 16, 2021
First Submitted That Met QC Criteria
April 20, 2021
First Posted (Actual)
April 21, 2021
Study Record Updates
Last Update Posted (Actual)
July 20, 2022
Last Update Submitted That Met QC Criteria
July 19, 2022
Last Verified
July 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- 2020/542
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tonsillar Disorder
-
University of HelsinkiCompleted
-
Pierre-Yves P LequeuxCompleted
-
Seoul National University HospitalSamsung Medical Center; Chung-Ang University Hosptial, Chung-Ang University... and other collaboratorsCompletedTonsillar HypertrophyKorea, Republic of
-
Pamukkale UniversityCompletedObstructive Tonsillar HypertrophyTurkey
-
ENTire Medical Ltd.Recruiting
-
Olubukola NafiuNot yet recruitingSurgery | Tonsillar Hypertrophy | Adenoid Hypertrophy
-
Rhode Island HospitalCompletedChildren, Only | Tonsillar Hypertrophy | Adenoid HypertrophyUnited States
-
Region Örebro CountyVärmland County Council, Sweden; Region Stockholm; Dalarna County Council, Sweden and other collaboratorsActive, not recruitingOropharynx Cancer | Oropharynx Squamous Cell Carcinoma | Base of the Tongue Carcinoma | Tonsillar CancerSweden
-
Imam Abdulrahman Bin Faisal UniversityCompletedPostoperative Pain | Inflammatory Response | Tonsillectomy | Peri-tonsillar Analgesic InfiltrationSaudi Arabia
-
Massachusetts Eye and Ear InfirmaryWithdrawnObstructive Sleep Apnea | Tonsillar Hypertrophy | Obstructive Sleep DisorderUnited States